CIGNPOST
DEAD

Serial Number

97257564

Owner

Cignpost Investments Limited

Attorney

Charles P. Bacall

Filing Date

Feb 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CIGNPOST Trademark

Serial Number: 97257564

CIGNPOST is a trademark filed by Cignpost Investments Limited on February 8, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cignpost Investments Limited (4 trademarks)

Building X92 Cody Technology Park
Farnborough, Hampshire GU140LX , GB

Entity Type: 99

Trademark Details

Filing Date

February 8, 2022

Registration Date

Not Registered

Goods & Services

Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical information; Medical consultation; Medical counselling; Medical services; Medical clinics; Medical screening; Medical evaluation services for patients with viruses; Medical advisory services relating to the treatment of patients; Providing medical information services; Medical analysis services relating to the treatment of persons; Medical information services; Medical care services; Medical treatment services for the treatment of COVID-19; Medical clinic services; Medical equipment rental; Medical assistance services; Medical health assessment services; Medical examination services of individuals; Rental of medical equipment; Rental of medical apparatus; Leasing of medical equipment; Provision of medical facilities; Provision of medical services; Conducting of medical examinations services; Mobile medical clinic services; Medical and managed healthcare services; Genetic testing for medical purposes; DNA screening for medical purposes; Medical and health services in the nature of DNA, genetics and genetic testing; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical analysis services for the diagnosis of COVID 19; Medical analysis for the diagnosis and treatment of persons; RNA and DNA analysis for COVID-19 diagnosis and screening services; COVID-19 screening services; on-site COVID-19 screening and testing services; temperature checking services as part of COVID-19 screening services; information, advisory and consultancy services regarding the aforementioned services

Electromedical diagnostic instruments for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of blood and saliva; Medical diagnostic saliva collection pads; Fingerstalls in the nature of support bandages for diagnostic purposes; Medical diagnostic saliva collection vials; Ultrasonic medical diagnostic apparatus; Tools for medical diagnostics, namely, swabs, needles and other blood taking tools; Diagnostic instruments for medical use, namely, diagnosing COVID-19 or underlying health issues; Diagnostic, examination, and monitoring equipment, namely, body composition monitors, heart rate monitors and blood pressure monitors; Diagnostic apparatus for medical purposes for testing for COVID-19 and underlying health conditions; diagnostic measuring apparatus for medical use, namely, analyzing blood and measuring composition of the body; Medical diagnostic apparatus for medical purposes, namely, blood testing apparatus and blood pressure measuring apparatus; Testing probes for medical diagnostic purposes; Testing instruments for medical diagnostic purposes, namely, blood and saliva testing; Diagnostic imaging apparatus for medical use in the nature of an x-ray apparatus; Medical diagnostic apparatus for testing for viruses; Medical diagnostic testing apparatus for use in immunoassay procedures; Apparatus for carrying-out diagnostic tests for medical purposes, namely, syringes for medical purposes; Medical spittoons; Medical gowns; Medical masks for use by medical personnel; Medical instruments for use in cardiovascular screening and blood analysis procedures; Medical devices for detecting Covid-19 and underlying health issues; Medical examination gloves; Medical analytical apparatus for medical purposes, namely, blood testing apparatus; Medical analysis instruments, namely, syringes for medical purposes; Medical testing instruments for use in analyzing blood and identifying issues; Latex medical gloves; Gloves for medical examinations; Respirators for artificial respiration for medical purposes; Medical bags designed to hold medical instruments in the nature of blood testing apparatus; Containers for medical waste; Nebulizers for medical use; Gloves for medical use; X-ray CT scanners for medical diagnosis; Inhalers for medical use; Hematology analyzers for medical diagnostic use; Medical apparatus and devices, namely, syringes for medical purposes; Medical apparatus and instruments, namely, blood testing apparatus; Respiratory masks for medical purposes; Examination gloves for medical use; Detecting instruments for medical use, namely, biosensors for detecting infectious diseases; Respiration monitors for medical use; Temperature meters for medical use; Medical apparatus for assisting breathing; Portable nebulisers for medical purposes; Scanning instruments for medical use, namely, myocardial ischemia scanning devices; Scanning machines for medical use, namely, medical x-ray apparatus; Scanning apparatus for medical use, namely, x-ray apparatus; Digital thermometers for medical purposes; Hematology automatic analyzers for medical diagnosis; Pulse measuring devices for medical use; Specimen samplers for medical use, namely, medical specimen bags for holding body fluid samples for testing; Analytical instruments for medical use, namely, analysis of blood samples; Test equipment for medical use, namely, blood and saliva testing; Electronic temperature monitors for medical use; Protective clothing for medical purposes, namely, personal protective equipment; Test probes for medical use; Testing probes for medical purposes; diagnostic testing apparatus for medical purposes for viruses; Medical instruments for infectious disease testing; Lung function test apparatus for medical use; Apparatus for blood testing for medical purposes; Diagnostic testing instruments for use in immunoassay procedure; Apparatus for DNA and RNA testing for medical purposes; Medical probes; Probes for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 5, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 5, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 5, 2023 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 20, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 20, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 15, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 15, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 15, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2023 CRFA
ASSIGNED TO LIE
Mar 3, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 1, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 15, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2022 NWOS
NEW APPLICATION ENTERED
Feb 11, 2022 NWAP